USE OF ULIPRISTAL FOR TREATING UTERINE FIBROIDS

• 收藏
• 分享

专利权人:

UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;LABORATOIRE HRA-PHARMA

发明人:

GAINER, ERIN,NIEMAN, LYNNETTE,ULMANN, ANDRE,BLITHE, DIANA

申请号：

NZ58743909

公开号：

NZ587439A

申请日:

2009.01.28

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed is The use of an effective amount of 17alpha-acetoxy-11beta-[4-N, N-dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) or any metabolite thereof for the manufacture of a medicament for reducing or stopping bleeding in a patient afflicted with uterine fibroids； preventing or treating anaemia in a patient afflicted with uterine fibroids or treating metastatic leiomyoma. The ulipristal acetate metabolite is selected from the group consisting of CDB-3877, CDB-3963, CDB-3236, and CDB-4183.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/